| 000 | 01422 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514191955.0 | ||
| 264 | 0 | _c20040824 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1522-1059 | ||
| 024 | 7 |
_a10.1208/ps060106 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRowland, Malcolm | |
| 245 | 0 | 0 |
_aPhysiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002). _h[electronic resource] |
| 260 |
_bAAPS pharmSci _cFeb 2004 |
||
| 300 |
_aE6 p. _bdigital |
||
| 500 | _aPublication Type: Congress; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aChemistry, Pharmaceutical _xeducation |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aEnvironmental Health _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aPharmacokinetics |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSoftware |
| 650 | 0 | 4 |
_aToxicology _xmethods |
| 700 | 1 | _aBalant, Luc | |
| 700 | 1 | _aPeck, Carl | |
| 773 | 0 |
_tAAPS pharmSci _gvol. 6 _gno. 1 _gp. E6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1208/ps060106 _zAvailable from publisher's website |
| 999 |
_c14904801 _d14904801 |
||